Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations
-
* Corresponding author: Francisco J de Abajo fabajo@agemed.es
BMC Clinical Pharmacology 2001, 1:1-1 doi:10.1186/1472-6904-1-1
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 29 Nov 2000 | |
| Resubmission - Version 2 | Manuscript | 12 Feb 2001 | |
| Published | 13 Feb 2001 |